Press

About Acurable

The company

• Acurable is a venture-backed, fast growing medical devices company with offices in London and Seville.
• We create accurate and user-friendly wearable medical devices intended to be used by patients at home.

The AcuPebble technology

• Our award-winning, patented technology enables for the first time non-invasive, continuous and accurate monitoring of breathing biosignals.
• It is a breakthrough in respiratory medicine and the product of more than 10 years’ research at Imperial College London by Acurable’s founder, Professor Esther Rodriguez Villegas.
• The first two applications of the technology are in sleep apnoea diagnosis and clinical research monitoring of patients.
• In parallel, Acurable continues its R&D efforts to complete and launch additional products that will fundamentally improve other areas of healthcare such as the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) and the management of COPD exacerbations.

Products

AcuPebble SA100 is the first medical device to obtain the CE mark for the automated diagnosis of Obstructive Sleep Apnoea.

• It offers a clinically validated automated diagnosis
• It is comfortable and easy to use by patients at home
• It is cost-efficient and a reliable home sleep test

Key facts

• Founded in 2016 by Prof. Esther Rodriguez-Villegas, Emilio Sanz Pereiras and Dr Anas Imtiaz (founder bios).
• Based on over 10 years of research at Imperial College London (more about our story).
• Winner of XPrize in 2014, the most prestigious prize in the medical technology industry.
• First product focused on improving diagnosis of sleep apnoea (more about AcuPebble SA100).
• Raised £2.1m investment from VCs Kindred Capital and Alma Mundi Ventures (2017).
• Awarded two Innovate UK grants worth £1.4m (2019).
• Obtained CE mark as class IIa medical device (2020).